Protein Therapeutics Analysis

Protein therapeutics, like monoclonal antibodies and biosimilars, are produced using recombinant DNA technology. This process is complex and subject to risks of degradation and contamination, as temperature, storage conditions, and changes in pH can negatively impact the final product.​

Analytical approaches and workflows play a crucial role in comprehensive characterization, saving time and development costs. Thermo Fisher Scientific solutions are fit-for-purpose for monitoring product microheterogeneity throughout process development and manufacturing, helping to ensure drug safety and efficacy.